Alliance for Biosecurity Elects Chief Executive Officers of Bavarian Nordic

Alliance For Biosecurity Elects Chief Executive Officers Of Bavarian Nordic

Filed under: drug treatment programs washington dc

WASHINGTON, July 1, 2013 /PRNewswire/ — The Alliance for Biosecurity announced it recently elected Anders Hedegaard, President and CEO, Bavarian Nordic, and Elizabeth Posillico, PhD, President and CEO, Elusys Therapeutics, as its new co-chairs. … on …
Read more on PR Newswire (press release)

 

CEO of Patient Advocate Foundation Cites Increase in Patients Steered from

Filed under: drug treatment programs washington dc

Washington, DC – National Patient Advocate Foundation (PAF) Founder and CEO Nancy Davenport-Ennis testified today before the Energy and Commerce Health Subcommittee on the impact cuts to Medicare Part B drugs could have on patient access to critical …
Read more on Patient Advocate Foundation

 

DC Week: New Draft of SGR Bill Released

Filed under: drug treatment programs washington dc

WASHINGTON — Republicans in Congress unveiled their latest draft of legislation to replace Medicare's system of paying doctors, to cap off a week that went from Supreme Court decisions to immigration reform. House Releases Latest SGR Replacement Bill.
Read more on MedPage Today

 

Dr. Alen Salerian, Well-Known DC Psychiatrist, Invites Public Debate On

Filed under: drug treatment programs washington dc

David Sanford of Sanford Heisler, LLP in Washington, D.C., said that "Dr. Salerian will appeal the Board of Medicine decision and we are confident that the D.C. Court of Appeals will overturn it." … Most recently, Dr. Salerian founded and practiced …
Read more on Sacramento Bee